Industry Research Reports
Home > Reports > Service & Software > Global Omics Data Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Omics Data Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-03-12
Pages: 144 Pages
Report ld: 6257122
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Omics Data Analysis Service Market Size(US$)
CAGR 2026-2032
5.9%
Market Size,2032
USD 1,205
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 855 million
Market Forecast in 2032(Value)
US$ 1,205 million
CAGR
5.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Omics Data Analysis Service market is projected to grow from US$ 812 million in 2025 to US$ 1205 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Omics Data Analysis Service is a service that uses data generated by high-throughput omics technologies (such as sequencing, mass spectrometry, and microarrays) as its core, and combines multi-omics integrated analysis, machine learning, network modeling and other technologies to systematically analyze the composition, structure, function and interactions of biological molecules (DNA, RNA, proteins, metabolites, etc.).
From a downstream perspective, Developmental Biology accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Omics Data Analysis Service leading players (including Acobiom, AltraBio, BGI Genomics, Biogenity, Tempus, Cmbio, Creative Proteomics, Firalis Molecular Precision, Metware Biotechnology, Nuvisan, etc.), dominate supply; the top five capture approximately % of global revenue, with Acobiom leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Omics Data Analysis Service market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Acobiom
- AltraBio
- BGI Genomics
- Biogenity
- Tempus
- Cmbio
- Creative Proteomics
- Firalis Molecular Precision
- Metware Biotechnology
- Nuvisan
- Omics Data Solutions
- PharmaLex
- Standard BioTools
- PIPA AI
- Seven Bridges
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Genomic Analysis
- Transcriptomic Analysis
- Proteomic Analysis
- Metabolomic Analysis
- Epigenomic Analysis
- Microbiome Analysis
- Others
Segment by Application
- Developmental Biology
- Clinical Medicine
- Precision Diagnosis
- Drug Development
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Omics Data Analysis Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Omics Data Analysis Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Omics Data Analysis Service Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Genomic Analysis
1.2.3 Transcriptomic Analysis
1.2.4 Proteomic Analysis
1.2.5 Metabolomic Analysis
1.2.6 Epigenomic Analysis
1.2.7 Microbiome Analysis
1.2.8 Others
1.3 Market Segmentation by Application
1.3.1 Global Omics Data Analysis Service Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Developmental Biology
1.3.3 Clinical Medicine
1.3.4 Precision Diagnosis
1.3.5 Drug Development
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Omics Data Analysis Service Revenue Estimates and Forecasts (2021-2032)
2.2 Global Omics Data Analysis Service Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Omics Data Analysis Service Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Omics Data Analysis Service Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Genomic Analysis: Market Share by Key Players
3.3.2 Transcriptomic Analysis: Market Share by Key Players
3.3.3 Proteomic Analysis: Market Share by Key Players
3.3.4 Metabolomic Analysis: Market Share by Key Players
3.3.5 Epigenomic Analysis: Market Share by Key Players
3.3.6 Microbiome Analysis: Market Share by Key Players
3.3.7 Others: Market Share by Key Players
3.4 Global Omics Data Analysis Service Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Omics Data Analysis Service Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Omics Data Analysis Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Omics Data Analysis Service Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Omics Data Analysis Service Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Omics Data Analysis Service Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Omics Data Analysis Service Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Omics Data Analysis Service Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Omics Data Analysis Service Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Omics Data Analysis Service Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Omics Data Analysis Service Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Omics Data Analysis Service Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Omics Data Analysis Service Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Acobiom
11.1.1 Acobiom Corporation Information
11.1.2 Acobiom Business Overview
11.1.3 Acobiom Omics Data Analysis Service Product Features and Attributes
11.1.4 Acobiom Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.1.5 Acobiom Omics Data Analysis Service Revenue by Product in 2025
11.1.6 Acobiom Omics Data Analysis Service Revenue by Application in 2025
11.1.7 Acobiom Omics Data Analysis Service Revenue by Geographic Area in 2025
11.1.8 Acobiom Omics Data Analysis Service SWOT Analysis
11.1.9 Acobiom Recent Developments
11.2 AltraBio
11.2.1 AltraBio Corporation Information
11.2.2 AltraBio Business Overview
11.2.3 AltraBio Omics Data Analysis Service Product Features and Attributes
11.2.4 AltraBio Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.2.5 AltraBio Omics Data Analysis Service Revenue by Product in 2025
11.2.6 AltraBio Omics Data Analysis Service Revenue by Application in 2025
11.2.7 AltraBio Omics Data Analysis Service Revenue by Geographic Area in 2025
11.2.8 AltraBio Omics Data Analysis Service SWOT Analysis
11.2.9 AltraBio Recent Developments
11.3 BGI Genomics
11.3.1 BGI Genomics Corporation Information
11.3.2 BGI Genomics Business Overview
11.3.3 BGI Genomics Omics Data Analysis Service Product Features and Attributes
11.3.4 BGI Genomics Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.3.5 BGI Genomics Omics Data Analysis Service Revenue by Product in 2025
11.3.6 BGI Genomics Omics Data Analysis Service Revenue by Application in 2025
11.3.7 BGI Genomics Omics Data Analysis Service Revenue by Geographic Area in 2025
11.3.8 BGI Genomics Omics Data Analysis Service SWOT Analysis
11.3.9 BGI Genomics Recent Developments
11.4 Biogenity
11.4.1 Biogenity Corporation Information
11.4.2 Biogenity Business Overview
11.4.3 Biogenity Omics Data Analysis Service Product Features and Attributes
11.4.4 Biogenity Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.4.5 Biogenity Omics Data Analysis Service Revenue by Product in 2025
11.4.6 Biogenity Omics Data Analysis Service Revenue by Application in 2025
11.4.7 Biogenity Omics Data Analysis Service Revenue by Geographic Area in 2025
11.4.8 Biogenity Omics Data Analysis Service SWOT Analysis
11.4.9 Biogenity Recent Developments
11.5 Tempus
11.5.1 Tempus Corporation Information
11.5.2 Tempus Business Overview
11.5.3 Tempus Omics Data Analysis Service Product Features and Attributes
11.5.4 Tempus Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.5.5 Tempus Omics Data Analysis Service Revenue by Product in 2025
11.5.6 Tempus Omics Data Analysis Service Revenue by Application in 2025
11.5.7 Tempus Omics Data Analysis Service Revenue by Geographic Area in 2025
11.5.8 Tempus Omics Data Analysis Service SWOT Analysis
11.5.9 Tempus Recent Developments
11.6 Cmbio
11.6.1 Cmbio Corporation Information
11.6.2 Cmbio Business Overview
11.6.3 Cmbio Omics Data Analysis Service Product Features and Attributes
11.6.4 Cmbio Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.6.5 Cmbio Recent Developments
11.7 Creative Proteomics
11.7.1 Creative Proteomics Corporation Information
11.7.2 Creative Proteomics Business Overview
11.7.3 Creative Proteomics Omics Data Analysis Service Product Features and Attributes
11.7.4 Creative Proteomics Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.7.5 Creative Proteomics Recent Developments
11.8 Firalis Molecular Precision
11.8.1 Firalis Molecular Precision Corporation Information
11.8.2 Firalis Molecular Precision Business Overview
11.8.3 Firalis Molecular Precision Omics Data Analysis Service Product Features and Attributes
11.8.4 Firalis Molecular Precision Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.8.5 Firalis Molecular Precision Recent Developments
11.9 Metware Biotechnology
11.9.1 Metware Biotechnology Corporation Information
11.9.2 Metware Biotechnology Business Overview
11.9.3 Metware Biotechnology Omics Data Analysis Service Product Features and Attributes
11.9.4 Metware Biotechnology Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.9.5 Metware Biotechnology Recent Developments
11.10 Nuvisan
11.10.1 Nuvisan Corporation Information
11.10.2 Nuvisan Business Overview
11.10.3 Nuvisan Omics Data Analysis Service Product Features and Attributes
11.10.4 Nuvisan Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Omics Data Solutions
11.11.1 Omics Data Solutions Corporation Information
11.11.2 Omics Data Solutions Business Overview
11.11.3 Omics Data Solutions Omics Data Analysis Service Product Features and Attributes
11.11.4 Omics Data Solutions Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.11.5 Omics Data Solutions Recent Developments
11.12 PharmaLex
11.12.1 PharmaLex Corporation Information
11.12.2 PharmaLex Business Overview
11.12.3 PharmaLex Omics Data Analysis Service Product Features and Attributes
11.12.4 PharmaLex Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.12.5 PharmaLex Recent Developments
11.13 Standard BioTools
11.13.1 Standard BioTools Corporation Information
11.13.2 Standard BioTools Business Overview
11.13.3 Standard BioTools Omics Data Analysis Service Product Features and Attributes
11.13.4 Standard BioTools Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.13.5 Standard BioTools Recent Developments
11.14 PIPA AI
11.14.1 PIPA AI Corporation Information
11.14.2 PIPA AI Business Overview
11.14.3 PIPA AI Omics Data Analysis Service Product Features and Attributes
11.14.4 PIPA AI Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.14.5 PIPA AI Recent Developments
11.15 Seven Bridges
11.15.1 Seven Bridges Corporation Information
11.15.2 Seven Bridges Business Overview
11.15.3 Seven Bridges Omics Data Analysis Service Product Features and Attributes
11.15.4 Seven Bridges Omics Data Analysis Service Revenue and Gross Margin (2021-2026)
11.15.5 Seven Bridges Recent Developments
12 Omics Data Analysis Service Value Chain and Ecosystem Analysis
12.1 Omics Data Analysis Service Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Omics Data Analysis Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Omics Data Analysis Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Omics Data Analysis Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Omics Data Analysis Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Omics Data Analysis Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Omics Data Analysis Service Revenue by Region (US$ Million), 2021-2026
Table 5. Global Omics Data Analysis Service Revenue by Region (US$ Million), 2027-2032
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 7. Global Omics Data Analysis Service Revenue by Players (US$ Million), 2021-2026
Table 8. Global Omics Data Analysis Service Revenue-Based Market Share by Players (2021-2026)
Table 9. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 10. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Omics Data Analysis Service Revenue, 2025
Table 11. Global Omics Data Analysis Service Average Gross Margin (%) by Player (2021 vs 2025)
Table 12. Global Omics Data Analysis Service Companies Headquarters
Table 13. Global Omics Data Analysis Service Market Concentration Ratio (CR5)
Table 14. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Omics Data Analysis Service Revenue by Type (US$ Million), 2021-2026
Table 17. Global Omics Data Analysis Service Revenue by Type (US$ Million), 2027-2032
Table 18. Key Product Attributes and Differentiation
Table 19. Global Omics Data Analysis Service Revenue by Application (US$ Million), 2021-2026
Table 20. Global Omics Data Analysis Service Revenue by Application (US$ Million), 2027-2032
Table 21. Omics Data Analysis Service High-Growth Sectors Demand CAGR (2026-2032)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Omics Data Analysis Service Growth Accelerators and Market Barriers
Table 25. North America Omics Data Analysis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 26. Europe Omics Data Analysis Service Growth Accelerators and Market Barriers
Table 27. Europe Omics Data Analysis Service Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. Asia-Pacific Omics Data Analysis Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Omics Data Analysis Service Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 30. Central and South America Omics Data Analysis Service Investment Opportunities and Key Challenges
Table 31. Central and South America Omics Data Analysis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Middle East and Africa Omics Data Analysis Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Omics Data Analysis Service Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 34. Acobiom Corporation Information
Table 35. Acobiom Description and Major Businesses
Table 36. Acobiom Product Features and Attributes
Table 37. Acobiom Revenue (US$ Million) and Gross Margin (2021-2026)
Table 38. Acobiom Revenue Proportion by Product in 2025
Table 39. Acobiom Revenue Proportion by Application in 2025
Table 40. Acobiom Revenue Proportion by Geographic Area in 2025
Table 41. Acobiom Omics Data Analysis Service SWOT Analysis
Table 42. Acobiom Recent Developments
Table 43. AltraBio Corporation Information
Table 44. AltraBio Description and Major Businesses
Table 45. AltraBio Product Features and Attributes
Table 46. AltraBio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. AltraBio Revenue Proportion by Product in 2025
Table 48. AltraBio Revenue Proportion by Application in 2025
Table 49. AltraBio Revenue Proportion by Geographic Area in 2025
Table 50. AltraBio Omics Data Analysis Service SWOT Analysis
Table 51. AltraBio Recent Developments
Table 52. BGI Genomics Corporation Information
Table 53. BGI Genomics Description and Major Businesses
Table 54. BGI Genomics Product Features and Attributes
Table 55. BGI Genomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 56. BGI Genomics Revenue Proportion by Product in 2025
Table 57. BGI Genomics Revenue Proportion by Application in 2025
Table 58. BGI Genomics Revenue Proportion by Geographic Area in 2025
Table 59. BGI Genomics Omics Data Analysis Service SWOT Analysis
Table 60. BGI Genomics Recent Developments
Table 61. Biogenity Corporation Information
Table 62. Biogenity Description and Major Businesses
Table 63. Biogenity Product Features and Attributes
Table 64. Biogenity Revenue (US$ Million) and Gross Margin (2021-2026)
Table 65. Biogenity Revenue Proportion by Product in 2025
Table 66. Biogenity Revenue Proportion by Application in 2025
Table 67. Biogenity Revenue Proportion by Geographic Area in 2025
Table 68. Biogenity Omics Data Analysis Service SWOT Analysis
Table 69. Biogenity Recent Developments
Table 70. Tempus Corporation Information
Table 71. Tempus Description and Major Businesses
Table 72. Tempus Product Features and Attributes
Table 73. Tempus Revenue (US$ Million) and Gross Margin (2021-2026)
Table 74. Tempus Revenue Proportion by Product in 2025
Table 75. Tempus Revenue Proportion by Application in 2025
Table 76. Tempus Revenue Proportion by Geographic Area in 2025
Table 77. Tempus Omics Data Analysis Service SWOT Analysis
Table 78. Tempus Recent Developments
Table 79. Cmbio Corporation Information
Table 80. Cmbio Description and Major Businesses
Table 81. Cmbio Product Features and Attributes
Table 82. Cmbio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Cmbio Recent Developments
Table 84. Creative Proteomics Corporation Information
Table 85. Creative Proteomics Description and Major Businesses
Table 86. Creative Proteomics Product Features and Attributes
Table 87. Creative Proteomics Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Creative Proteomics Recent Developments
Table 89. Firalis Molecular Precision Corporation Information
Table 90. Firalis Molecular Precision Description and Major Businesses
Table 91. Firalis Molecular Precision Product Features and Attributes
Table 92. Firalis Molecular Precision Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. Firalis Molecular Precision Recent Developments
Table 94. Metware Biotechnology Corporation Information
Table 95. Metware Biotechnology Description and Major Businesses
Table 96. Metware Biotechnology Product Features and Attributes
Table 97. Metware Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. Metware Biotechnology Recent Developments
Table 99. Nuvisan Corporation Information
Table 100. Nuvisan Description and Major Businesses
Table 101. Nuvisan Product Features and Attributes
Table 102. Nuvisan Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Nuvisan Recent Developments
Table 104. Omics Data Solutions Corporation Information
Table 105. Omics Data Solutions Description and Major Businesses
Table 106. Omics Data Solutions Product Features and Attributes
Table 107. Omics Data Solutions Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Omics Data Solutions Recent Developments
Table 109. PharmaLex Corporation Information
Table 110. PharmaLex Description and Major Businesses
Table 111. PharmaLex Product Features and Attributes
Table 112. PharmaLex Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. PharmaLex Recent Developments
Table 114. Standard BioTools Corporation Information
Table 115. Standard BioTools Description and Major Businesses
Table 116. Standard BioTools Product Features and Attributes
Table 117. Standard BioTools Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. Standard BioTools Recent Developments
Table 119. PIPA AI Corporation Information
Table 120. PIPA AI Description and Major Businesses
Table 121. PIPA AI Product Features and Attributes
Table 122. PIPA AI Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. PIPA AI Recent Developments
Table 124. Seven Bridges Corporation Information
Table 125. Seven Bridges Description and Major Businesses
Table 126. Seven Bridges Product Features and Attributes
Table 127. Seven Bridges Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Seven Bridges Recent Developments
Table 129. Technologies, Platforms and Infrastructure
Table 130. Distributors List
Table 131. Market Trends and Market Evolution
Table 132. Market Drivers and Opportunities
Table 133. Market Challenges, Risks, and Restraints
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Omics Data Analysis Service Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Genomic Analysis Product Picture
Figure 3. Transcriptomic Analysis Product Picture
Figure 4. Proteomic Analysis Product Picture
Figure 5. Metabolomic Analysis Product Picture
Figure 6. Epigenomic Analysis Product Picture
Figure 7. Microbiome Analysis Product Picture
Figure 8. Others Product Picture
Figure 9. Global Omics Data Analysis Service Market Size Growth Rate , 2021 vs 2025 vs 2032 (US$ Million)
Figure 10. Global Omics Data Analysis Service Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Developmental Biology
Figure 12. Clinical Medicine
Figure 13. Precision Diagnosis
Figure 14. Drug Development
Figure 15. Others
Figure 16. Omics Data Analysis Service Report Years Considered
Figure 17. Global Omics Data Analysis Service Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 19. Global Omics Data Analysis Service Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 20. Global Omics Data Analysis Service Revenue-Based Market Share by Region (2021-2032)
Figure 21. Global Omics Data Analysis Service Revenue-Based Market Share Ranking (2025)
Figure 22. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 23. Genomic Analysis Revenue-Based Market Share by Player in 2025
Figure 24. Transcriptomic Analysis Revenue-Based Market Share by Player in 2025
Figure 25. Proteomic Analysis Revenue-Based Market Share by Player in 2025
Figure 26. Metabolomic Analysis Revenue-Based Market Share by Player in 2025
Figure 27. Epigenomic Analysis Revenue-Based Market Share by Player in 2025
Figure 28. Microbiome Analysis Revenue-Based Market Share by Player in 2025
Figure 29. Others Revenue-Based Market Share by Player in 2025
Figure 30. Global Omics Data Analysis Service Revenue-Based Market Share by Type (2021-2032)
Figure 31. Global Omics Data Analysis Service Revenue-Based Market Share by Application (2021-2032)
Figure 32. North America Omics Data Analysis Service Revenue YoY (US$ Million), 2021-2032
Figure 33. North America Top 5 Players Omics Data Analysis Service Revenue (US$ Million) in 2025
Figure 34. North America Omics Data Analysis Service Revenue (US$ Million) by Application (2021-2032)
Figure 35. US Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 36. Canada Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 37. Mexico Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 38. Europe Omics Data Analysis Service Revenue YoY (US$ Million), 2021-2032
Figure 39. Europe Top 5 Players Omics Data Analysis Service Revenue (US$ Million) in 2025
Figure 40. Europe Omics Data Analysis Service Revenue (US$ Million) by Application (2021-2032)
Figure 41. Germany Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 42. France Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 43. U.K. Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 44. Italy Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 45. Russia Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 46. Asia-Pacific Omics Data Analysis Service Revenue YoY (US$ Million), 2021-2032
Figure 47. Asia-Pacific Top 8 Players Omics Data Analysis Service Revenue (US$ Million) in 2025
Figure 48. Asia-Pacific Omics Data Analysis Service Revenue (US$ Million) by Application (2021-2032)
Figure 49. Indonesia Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 50. Japan Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 51. South Korea Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 52. Australia Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 53. India Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 54. Indonesia Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 55. Vietnam Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 56. Malaysia Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 57. Philippines Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 58. Singapore Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 59. Central and South America Omics Data Analysis Service Revenue YoY (US$ Million), 2021-2032
Figure 60. Central and South America Top 5 Players Omics Data Analysis Service Revenue (US$ Million) in 2025
Figure 61. Central and South America Omics Data Analysis Service Revenue (US$ Million) by Application (2021-2032)
Figure 62. Brazil Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 63. Argentina Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 64. Middle East and Africa Omics Data Analysis Service Revenue YoY (US$ Million), 2021-2032
Figure 65. Middle East and Africa Top 5 Players Omics Data Analysis Service Revenue (US$ Million) in 2025
Figure 66. Middle East and Africa Omics Data Analysis Service Revenue (US$ Million) by Application (2021-2032)
Figure 67. GCC Countries Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 68. Israel Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 69. Egypt Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 70. South Africa Omics Data Analysis Service Revenue (US$ Million), 2021-2032
Figure 71. Omics Data Analysis Service Value Chain Mapping
Figure 72. Channels of Distribution (Direct Vs Distribution)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Omics Data Analysis Service market?
The top companies in the global Omics Data Analysis Service market are Acobiom、AltraBio、BGI Genomics.
What was the global market size of Omics Data Analysis Service in 2032?
What was the global market size of Omics Data Analysis Service in 2026?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Omics Data Analysis Service market size from 2026 to 2032?
Related Reports
Global Omics Data Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Omics Data Analysis Service market size was US$ 812 million in 2025 and is forecast to reach a readjusted size of US$ 1205 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 94
USD 4250.00
(Single User License)
Global Omics Data Analysis Service Market Research Report 2026
The global Omics Data Analysis Service market was valued at US$ 812 million in 2025 and is anticipated to reach US$ 1205 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 120
USD 2900.00
(Single User License)
Omics Data Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Omics Data Analysis Service was estimated to be worth US$ 812 million in 2025 and is projected to reach US$ 1205 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 113
USD 3950.00
(Single User License)
Global Omics Data Analysis Service Market Research Report 2025
The global market for Omics Data Analysis Service was valued at US$ 745 million in the year 2024 and is projected to reach a revised size of US$ 1144 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-08-27
Pages: 89
USD 2900.00
(Single User License)
Global Omics Data Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Omics Data Analysis Service market is projected to grow from US$ 745 million in 2024 to US$ 1144 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-27
Pages: 137
USD 4900.00
(Single User License)
Omics Data Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Omics Data Analysis Service was estimated to be worth US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 117
USD 3950.00
(Single User License)
Global Omics Data Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Omics Data Analysis Service market size was US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-08-27
Pages: 92
USD 4250.00
(Single User License)
Global Omics Data Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Omics Data Analysis Service market size was US$ 812 million in 2025 and is forecast to reach a readjusted size of US$ 1205 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 94
USD 4250.00 (Single User License)Global Omics Data Analysis Service Market Research Report 2026
The global Omics Data Analysis Service market was valued at US$ 812 million in 2025 and is anticipated to reach US$ 1205 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-12
Pages: 120
USD 2900.00 (Single User License)Omics Data Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Omics Data Analysis Service was estimated to be worth US$ 812 million in 2025 and is projected to reach US$ 1205 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-09
Pages: 113
USD 3950.00 (Single User License)Global Omics Data Analysis Service Market Research Report 2025
The global market for Omics Data Analysis Service was valued at US$ 745 million in the year 2024 and is projected to reach a revised size of US$ 1144 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-08-27
Pages: 89
USD 2900.00 (Single User License)Global Omics Data Analysis Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Omics Data Analysis Service market is projected to grow from US$ 745 million in 2024 to US$ 1144 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-27
Pages: 137
USD 4900.00 (Single User License)Omics Data Analysis Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Omics Data Analysis Service was estimated to be worth US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 117
USD 3950.00 (Single User License)Global Omics Data Analysis Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Omics Data Analysis Service market size was US$ 745 million in 2024 and is forecast to a readjusted size of US$ 1144 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-08-27
Pages: 92
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now